TD-1607
0098
Phase 1 small_molecule completed
Quick answer
TD-1607 for Serious Infections Due to Known or Suspected Gram-positive Pathogens is a Phase 1 program (small_molecule) at Theravance Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Theravance Biopharma
- Indication
- Serious Infections Due to Known or Suspected Gram-positive Pathogens
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed